What does Phantom Neuro do?
Phantom Neuro is a neurotechnology company that develops a minimally invasive interface, Phantom X, which enables intuitive control of prosthetic limbs and robotic exoskeletons, aiming to restore natural movement for amputees and individuals with mobility impairments.
How much did they raise?
The company raised $19M in its Series A round, led by Ottobock with participation from Breakout Ventures, Draper Associates, LionBird Ventures, Time BioVentures, Risk and Return, Actual VC, METIS Innovative, e1 Ventures, Jumpspace, MainSheet Ventures, and Brown Advisory.
What are their plans for the money?
With the new funds, Phantom Neuro plans to support preclinical testing, complete first-in-human trials, initiate regulatory submissions, and expand its research and development efforts to explore broader control applications beyond prosthetic limbs, potentially transforming the way neurotechnologies integrate with human movement.
What have they achieved so far?
The company has already made strides with its core platform, Phantom X, demonstrating significant progress in enabling seamless integration between human intent and robotic device control, which paves the way for improved mobility solutions.
